ZNG1A Gene

Name Zn regulated GTPase metalloprotein activator 1A
Description Predicted to enable GTPase activity and zinc chaperone activity. Involved in kidney development. Predicted to be located in nucleus. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Mar 2025]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nAdropin (encoded by the Energy Homeostasis Associated gene) is a multifunctional peptide that plays a central role in energy balance and metabolic regulation. It is expressed predominantly in the liver and brain, and its circulating levels fluctuate in response to nutritional states – rising with high‐fat feeding and declining during fasting – with emerging protective effects against obesity‐associated insulin resistance and hepatosteatosis. These findings implicate adropin as a key mediator in maintaining glucose and lipid homeostasis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its systemic metabolic actions, adropin has been shown to affect substrate oxidation preferences and hepatic glucose production. In skeletal muscle, it favors carbohydrate oxidation by activating pyruvate dehydrogenase and suppressing enzymes involved in fatty acid metabolism, while in the liver it enhances insulin signaling, alleviates endoplasmic reticulum stress, and curbs gluconeogenesis by modulating key transcriptional coregulators and intracellular kinases. In adipose cells, adropin stimulates preadipocyte proliferation via ERK1/2 and AKT but attenuates their differentiation into fat‐storing cells. Moreover, caloric restriction studies indicate that adropin levels remain elevated to counterbalance hyperglycemia and metabolic syndrome features, an observation extended even to its clinical correlations with nonalcoholic fatty liver disease severity."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "3", "end_ref": "10"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAdropin also exerts beneficial effects on the vasculature. Studies in animal models and humans demonstrate that its decline with aging is accompanied by impaired endothelial nitric oxide synthase activation and vascular dysfunction, whereas aerobic exercise restores both arterial and circulating levels of adropin. This restoration is paralleled by improved endothelial function and enhanced nitric oxide production, underscoring a therapeutic potential for vascular aging and atherosclerotic disorders."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the central nervous system, a membrane‐associated form of adropin is highly expressed in the brain where it interacts with the NB-3/Contactin 6 ligand to potentiate Notch signaling. This interaction promotes the activation of downstream Notch target genes, and its disruption (as seen in adropin knockout mice) is associated with impaired synapse formation, decreased locomotor activity, and defects in motor coordination—thus linking adropin to proper cerebellar development and neural function."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAdropin is also emerging as a regulator of ovarian physiology. Experimental studies in pre‐pubertal mice reveal that adropin is expressed in ovarian compartments where it correlates positively with steroid hormone production. Administration of adropin promotes early folliculogenesis by enhancing granulosa cell proliferation and upregulating key steroidogenic proteins, suggesting a role in accelerating pubertal development and potentially offering therapeutic avenues for pubertal delay."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the context of immune modulation and inflammatory injury, adropin has been implicated in dampening pro‐inflammatory responses. For instance, in models of acute pancreatitis–associated lung injury and in vascular inflammatory conditions like ANCA-associated vasculitis, adropin modulates macrophage polarization toward an anti-inflammatory M2 phenotype and regulates the expression of critical transcriptional factors, including distinct PPAR isoforms. These actions contribute to reduced tissue fibrosis, diminished apoptosis, and improved overall tissue recovery following inflammatory insults."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFinally, while adropin has been extensively studied for its diverse roles in energy metabolism, vascular function, neural signaling, and immune regulation, its involvement in congenital developmental disorders—for example, congenital anomalies of the kidney and urinary tract (CAKUT)—has not been substantiated, highlighting the specificity of its biological functions."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "17"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "K Ganesh Kumar, James L Trevaskis, Daniel D Lam, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Metab (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cmet.2008.10.011"}], "href": "https://doi.org/10.1016/j.cmet.2008.10.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19041763"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19041763"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Fina Lovren, Yi Pan, Adrian Quan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Adropin is a novel regulator of endothelial function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circulation (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCULATIONAHA.109.931782"}], "href": "https://doi.org/10.1161/CIRCULATIONAHA.109.931782"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20837912"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20837912"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Su Gao, Ryan P McMillan, Jordi Jacas, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of substrate oxidation preferences in muscle by the peptide hormone adropin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/db14-0388"}], "href": "https://doi.org/10.2337/db14-0388"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24848071"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24848071"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Bilge G Tuna, Pinar B Atalay, Mine Altunbek, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effects of Chronic and Intermittent Calorie Restriction on Adropin Levels in Breast Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nutr Cancer (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/01635581.2017.1359314"}], "href": "https://doi.org/10.1080/01635581.2017.1359314"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28922017"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28922017"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Kengo Sato, Tomoyuki Yamashita, Remina Shirai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Adropin Contributes to Anti-Atherosclerosis by Suppressing Monocyte-Endothelial Cell Adhesion and Smooth Muscle Cell Proliferation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms19051293"}], "href": "https://doi.org/10.3390/ijms19051293"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29701665"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29701665"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Su Gao, Sarbani Ghoshal, Liyan Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The peptide hormone adropin regulates signal transduction pathways controlling hepatic glucose metabolism in a mouse model of diet-induced obesity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.RA119.008967"}], "href": "https://doi.org/10.1074/jbc.RA119.008967"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31324719"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31324719"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Mariami Jasaszwili, Tatiana Wojciechowicz, Maria Billert, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effects of adropin on proliferation and differentiation of 3T3-L1 cells and rat primary preadipocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Endocrinol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mce.2019.110532"}], "href": "https://doi.org/10.1016/j.mce.2019.110532"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31400396"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31400396"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Xu Chen, Shen Chen, Tianran Shen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Adropin regulates hepatic glucose production via PP2A/AMPK pathway in insulin-resistant hepatocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.202000115RR"}], "href": "https://doi.org/10.1096/fj.202000115RR"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32579277"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32579277"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Xu Chen, Xiaoyuan Sun, Tianran Shen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Lower adropin expression is associated with oxidative stress and severity of nonalcoholic fatty liver disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Free Radic Biol Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.freeradbiomed.2020.08.005"}], "href": "https://doi.org/10.1016/j.freeradbiomed.2020.08.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32810635"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32810635"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Wenqi Yang, Ling Liu, Yuan Wei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exercise suppresses NLRP3 inflammasome activation in mice with diet-induced NASH: a plausible role of adropin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lab Invest (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41374-020-00508-y"}], "href": "https://doi.org/10.1038/s41374-020-00508-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33268842"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33268842"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Shumpei Fujie, Natsuki Hasegawa, Naoki Horii, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Aerobic Exercise Restores Aging-Associated Reductions in Arterial Adropin Levels and Improves Adropin-Induced Nitric Oxide-Dependent Vasorelaxation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Am Heart Assoc (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/JAHA.120.020641"}], "href": "https://doi.org/10.1161/JAHA.120.020641"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33938228"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33938228"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Bingda Li, Zhenhua Wang, Yuanqiao He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Adropin Improves Radiation-Induced Myocardial Injury via VEGFR2/PI3K/Akt Pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oxid Med Cell Longev (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2022/8230214"}], "href": "https://doi.org/10.1155/2022/8230214"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35923860"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35923860"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Chi-Ming Wong, Yudong Wang, Jimmy Tsz Hang Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Adropin is a brain membrane-bound protein regulating physical activity via the NB-3/Notch signaling pathway in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M114.576058"}], "href": "https://doi.org/10.1074/jbc.M114.576058"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25074942"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25074942"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Shweta Maurya, Shashank Tripathi, Ajit Singh "}, {"type": "b", "children": [{"type": "t", "text": "Ontogeny of adropin and its receptor expression during postnatal development and its pro-gonadal role in the ovary of pre-pubertal mouse."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Steroid Biochem Mol Biol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jsbmb.2023.106404"}], "href": "https://doi.org/10.1016/j.jsbmb.2023.106404"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37743028"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37743028"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Qingquan Chen, Youzhu Li, Xinxin Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Selective deficiency of UCP-1 and adropin may lead to different subtypes of anti-neutrophil cytoplasmic antibody-associated vasculitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Immun (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41435-023-00195-x"}], "href": "https://doi.org/10.1038/s41435-023-00195-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36670189"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36670189"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Fadian Ding, Guozhong Liu, Feng Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Adropin attenuates pancreatitis‑associated lung injury through PPARγ phosphorylation‑related macrophage polarization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Med (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijmm.2023.5298"}], "href": "https://doi.org/10.3892/ijmm.2023.5298"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37654184"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37654184"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Shoichiro Kanda, Masaki Ohmuraya, Hiroyuki Akagawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deletion in the "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "Cobalamin Synthetase W Domain-Containing Protein 1"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " Gene Is associated with Congenital Anomalies of the Kidney and Urinary Tract."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Am Soc Nephrol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1681/ASN.2019040398"}], "href": "https://doi.org/10.1681/ASN.2019040398"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31862704"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31862704"}]}]}]}
NCBI Gene ID 55871
API
Download Associations
Predicted Functions View ZNG1A's ARCHS4 Predicted Functions.
Co-expressed Genes View ZNG1A's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View ZNG1A's ARCHS4 Predicted Functions.

Functional Associations

ZNG1A has 1,226 functional associations with biological entities spanning 6 categories (chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 20 datasets.

Click the + buttons to view associations for ZNG1A from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of ZNG1A gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of ZNG1A gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CellMarker Gene-Cell Type Associations cell types associated with ZNG1A gene from the CellMarker Gene-Cell Type Associations dataset.
CM4AI KOLF21J CRISPRi Gene Perturbation Atlas gene perturbations changing expression of ZNG1A gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with ZNG1A protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
GO Biological Process Annotations 2025 biological processes involving ZNG1A gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2025 cellular components containing ZNG1A protein from the curated GO Cellular Component Annotations 2025 dataset.
GTEx eQTL 2025 SNPs regulating expression of ZNG1A gene from the GTEx eQTL 2025 dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of ZNG1A gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with ZNG1A gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of ZNG1A gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of ZNG1A gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of ZNG1A gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of ZNG1A gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of ZNG1A gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of ZNG1A gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of ZNG1A gene from the RummaGEO Gene Perturbation Signatures dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of ZNG1A protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of ZNG1A protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with ZNG1A protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.